Targeted Oncology: Novel CTLA-4 Agents Build on Immunotherapy Foundation, Aim to Improve Efficacy/Safety
GIGA-564 featured in the Next Wave of CTLA-4 Blockade. Read the full article.
GIGA-564 featured in the Next Wave of CTLA-4 Blockade. Read the full article.